Source: BioSpace

Otonomy: Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board

Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the completion of its acquisition of selected assets from Otonomy, Inc.

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
David A Weber's photo - President & CEO of Otonomy

President & CEO

David A Weber

CEO Approval Rating

88/100

Read more